CAPSTONE THERAPEUTICS CORP COM STK (DE)
CAPS
CAPS was delisted on the 20th of July, 2011.
2 hedge funds and large institutions have $5K invested in CAPSTONE THERAPEUTICS CORP COM STK (DE) in 2013 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
400% more capital invested
Capital invested by funds: $1K → $5K (+$4K)
100% more funds holding
Funds holding: 1 → 2 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EARNEST Partners
Atlanta,
Georgia
|
+$4K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
EARNEST Partners
Atlanta,
Georgia
| $4K | +$4K | +16,000 | New |
|
|
MWP
2
MYCIO Wealth Partners
Philadelphia,
Pennsylvania
| $1K | – | – | – |
|
CAPS Hedge Fund Activity: Q4 2013 in Review
2 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in CAPSTONE THERAPEUTICS CORP COM STK (DE) (CAPS) for Q4 2013, worth a combined $5K — up 400% from $1K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CAPS positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was EARNEST Partners, opening a new position worth an estimated $4K.
- 2 institutional investors held CAPSTONE THERAPEUTICS CORP COM STK (DE) (CAPS) as of Q4 2013, up from 1 in Q3 2013.
- Funds reported $5K of CAPSTONE THERAPEUTICS CORP COM STK (DE) stock for Q4 2013, up 400% quarter-over-quarter.
- 1 fund opened new CAPSTONE THERAPEUTICS CORP COM STK (DE) positions in Q4 2013 and 0 closed out, a net change of +1 holder.
- The largest CAPSTONE THERAPEUTICS CORP COM STK (DE) buyer in Q4 2013 was EARNEST Partners, an estimated $4K added.
Based on aggregated 13F filings for Q4 2013.